Rose-John S - Search Results

1

Intravitreal injection of anti-Interleukin (IL)-6 antibody attenuates experimental autoimmune uveitis in mice.

Tode J, Richert E, Koinzer S, Klettner A, Pickhinke U, Garbers C, Rose-John S, Nölle B, Roider J. Tode J, et al. Cytokine. 2017 Aug;96:8-15. doi: 10.1016/j.cyto.2017.02.023. Epub 2017 Mar 6. Cytokine. 2017. PMID: 28267649

2

Interleukin-6 trans-signaling regulates glycogen consumption after D-galactosamine-induced liver damage.

Drucker C, Rabe B, Chalaris A, Schulz E, Scheller J, Rose-John S. Drucker C, et al. J Interferon Cytokine Res. 2009 Nov;29(11):711-8. doi: 10.1089/jir.2008.0095. J Interferon Cytokine Res. 2009. PMID: 19642894

3

Essential role of neutrophil mobilization in concanavalin A-induced hepatitis is based on classic IL-6 signaling but not on IL-6 trans-signaling.

Malchow S, Thaiss W, Jänner N, Waetzig GH, Gewiese-Rabsch J, Garbers C, Yamamoto K, Rose-John S, Scheller J. Malchow S, et al. Biochim Biophys Acta. 2011 Mar;1812(3):290-301. doi: 10.1016/j.bbadis.2010.11.009. Epub 2010 Dec 2. Biochim Biophys Acta. 2011. PMID: 21130161 Free article.

4

The soluble Interleukin 6 receptor: generation and role in inflammation and cancer.

Chalaris A, Garbers C, Rabe B, Rose-John S, Scheller J. Chalaris A, et al. Eur J Cell Biol. 2011 Jun-Jul;90(6-7):484-94. doi: 10.1016/j.ejcb.2010.10.007. Epub 2010 Dec 8. Eur J Cell Biol. 2011. PMID: 21145125 Review.

5

Species specificity of ADAM10 and ADAM17 proteins in interleukin-6 (IL-6) trans-signaling and novel role of ADAM10 in inducible IL-6 receptor shedding.

Garbers C, Jänner N, Chalaris A, Moss ML, Floss DM, Meyer D, Koch-Nolte F, Rose-John S, Scheller J. Garbers C, et al. J Biol Chem. 2011 Apr 29;286(17):14804-11. doi: 10.1074/jbc.M111.229393. Epub 2011 Mar 15. J Biol Chem. 2011. PMID: 21454673 Free PMC article.

6

ADAM17: a molecular switch to control inflammation and tissue regeneration.

Scheller J, Chalaris A, Garbers C, Rose-John S. Scheller J, et al. Trends Immunol. 2011 Aug;32(8):380-7. doi: 10.1016/j.it.2011.05.005. Epub 2011 Jul 13. Trends Immunol. 2011. PMID: 21752713 Review.

7

Inhibition of classic signaling is a novel function of soluble glycoprotein 130 (sgp130), which is controlled by the ratio of interleukin 6 and soluble interleukin 6 receptor.

Garbers C, Thaiss W, Jones GW, Waetzig GH, Lorenzen I, Guilhot F, Lissilaa R, Ferlin WG, Grötzinger J, Jones SA, Rose-John S, Scheller J. Garbers C, et al. J Biol Chem. 2011 Dec 16;286(50):42959-70. doi: 10.1074/jbc.M111.295758. Epub 2011 Oct 11. J Biol Chem. 2011. PMID: 21990364 Free PMC article.

8

Hitting a complex target: an update on interleukin-6 trans-signalling.

Waetzig GH, Rose-John S. Waetzig GH, et al. Expert Opin Ther Targets. 2012 Feb;16(2):225-36. doi: 10.1517/14728222.2012.660307. Expert Opin Ther Targets. 2012. PMID: 22324903 Review.

9

Constitutively active mutant gp130 receptor protein from inflammatory hepatocellular adenoma is inhibited by an anti-gp130 antibody that specifically neutralizes interleukin 11 signaling.

Sommer J, Effenberger T, Volpi E, Waetzig GH, Bernhardt M, Suthaus J, Garbers C, Rose-John S, Floss DM, Scheller J. Sommer J, et al. J Biol Chem. 2012 Apr 20;287(17):13743-51. doi: 10.1074/jbc.M111.349167. J Biol Chem. 2012. PMID: 22523320 Free PMC article.

10

The membrane-proximal domain of A Disintegrin and Metalloprotease 17 (ADAM17) is responsible for recognition of the interleukin-6 receptor and interleukin-1 receptor II.

Lorenzen I, Lokau J, Düsterhöft S, Trad A, Garbers C, Scheller J, Rose-John S, Grötzinger J. Lorenzen I, et al. FEBS Lett. 2012 Apr 24;586(8):1093-100. doi: 10.1016/j.febslet.2012.03.012. Epub 2012 Mar 21. FEBS Lett. 2012. PMID: 22575642 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

606 results

Search Page